World's Best Scientists 2026 revealed!
Klaus Bendtzen

Klaus Bendtzen

Award Badge
Immunology
Denmark
2026

D-Index & Metrics

Immunology

D-Index
88
Citations
27233
World Ranking
1171
National Ranking
7

Medicine

D-Index
88
Citations
27234
World Ranking
13201
National Ranking
143

Klaus Bendtzen publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Klaus Bendtzen sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 533 publications — 91st percentile

91% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Klaus Bendtzen D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Klaus Bendtzen sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 88 D-Index — 77th percentile

77% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 2026 - Research.com Immunology in Denmark Leader Award
  • 2025 - Research.com Immunology in Denmark Leader Award
  • 2023 - Research.com Immunology in Denmark Leader Award
  • 2022 - Research.com Immunology in Denmark Leader Award

Overview

Klaus Bendtzen is affiliated with Rigshospitalet in Denmark and has a broad research portfolio primarily in medicine and biochemistry, genetics, and molecular biology. Their published work spans subfields such as molecular biology, pulmonary and respiratory medicine, immunology, infectious diseases, and epidemiology.

The scientist's research encompasses multiple main topics, including:

  • Respiratory Support and Mechanisms
  • Ion Transport and Channel Regulation
  • COVID-19 Clinical Research Studies
  • Immune cells in cancer
  • Ion channel regulation and function
  • Pneumonia and Respiratory Infections
  • Immune Response and Inflammation

Bendtzen's frequently published papers include the following titles:

  • Update on the Features and Measurements of Experimental Acute Lung Injury in Animals: An Official American Thoracic Society Workshop Report (2022), American Journal of Respiratory Cell and Molecular Biology
  • Mice with a specific deficiency of Pfkfb3 in myeloid cells are protected from hypoxia-induced pulmonary hypertension (2020), British Journal of Pharmacology
  • Impact of Bacterial Toxins in the Lungs (2020), Toxins
  • Mechanisms of pulmonary endothelial barrier dysfunction in acute lung injury and acute respiratory distress syndrome (2024), Chinese Medical Journal - Pulmonary and Critical Care Medicine
  • Receptor-independent fluid-phase macropinocytosis promotes arterial foam cell formation and atherosclerosis (2022), Science Translational Medicine

Their coauthors most frequently include David Fulton, Yunchao Su, Jürg Hamacher, Alexander D. Verin, and Masuko Ushio-Fukai.

Common publication venues for Bendtzen's research are:

  • Frontiers in Immunology
  • Free Radical Biology and Medicine
  • American Journal of Respiratory Cell and Molecular Biology
  • Toxins
  • PLoS ONE

Regarding book publications, Bendtzen has contributed to Frontiers Media with a title named Insights in Inflammation: 2022, published in 2023.

Best Publications

  • Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.

    Pål Aukrust;Thor Ueland;Egil Lien;Klaus Bendtzen

  • Cytotoxicity of human pI 7 interleukin-1 for pancreatic islets of Langerhans.

    Klaus Bendtzen;Thomas Mandrup-Poulsen;Jørn Nerup;Jens H. Nielsen

  • Individualized monitoring of drug bioavailability and immunogenicity in rheumatoid arthritis patients treated with the tumor necrosis factor alpha inhibitor infliximab.

    Klaus Bendtzen;Pierre Geborek;Morten Svenson;Lotta Larsson

  • Individualised therapy is more cost-effective than dose intensification in patients with Crohn’s disease who lose response to anti-TNF treatment: a randomised, controlled trial

    Casper Steenholdt;Jørn Brynskov;Ole Østergaard Thomsen;Lars Kristian Munck

  • Prognostic laboratory markers of joint damage in rheumatoid arthritis

    Elisabet Lindqvist;Kerstin Eberhardt;Klaus Bendtzen;Dick Heinegard

  • Formation of antibodies against infliximab and adalimumab strongly correlates with functional drug levels and clinical responses in rheumatoid arthritis

    T.R.D.J. Radstake;M. Svenson;A.M.M. Eijsbouts;F.H.J. van den Hoogen

  • Interleukin-lβ-Induced Nitric Oxide Production in Isolated Rat Pancreatic Islets Requires Gene Transcription and May Lead to Inhibition of the Krebs Cycle Enzyme Aconitase

    Nils Welsh;Decio L. Eizirik;Klaus Bendtzen;Stellan Sandler

  • Affinity-purified human Interleukin I is cytotoxic to isolated islets of Langerhans

    T. Mandrup-Poulsen;K. Bendtzen;J. Nerup;C. A. Dinarello

  • Clinical importance of neutralising antibodies against interferon beta in patients with relapsing-remitting multiple sclerosis.

    Per Soelberg Sorensen;Christian Ross;Katja Maria Clemmesen;Klaus Bendtzen

  • Cytokines suppress human islet function irrespective of their effects on nitric oxide generation.

    Décio L. Eizirik;Stellan Sandler;Nils Welsh;Marina Cetkovic-Cvrlje

  • Human tumor necrosis factor potentiates human interleukin 1-mediated rat pancreatic beta-cell cytotoxicity.

    T Mandrup-Poulsen;K Bendtzen;C A Dinarello;J Nerup

  • Extraintestinal manifestations of inflammatory bowel disease: epidemiology, diagnosis, and management.

    Signe Larsen;Klaus Bendtzen;Ole Haagen Nielsen

  • Interleukin 1, interleukin 6 and tumor necrosis factor in infection, inflammation and immunity.

    Klaus Bendtzen

  • Immunogenicity of interferon‐β in multiple sclerosis patients: Influence of preparation, dosage, dose frequency, and route of administration

    Christian Ross;Katja Maria Clemmesen;Morten Svenson;Per Soelberg Sørensen

  • Autoantibodies to cytokines - friends or foes?

    Klaus Bendtzen;Morten Svenson;Viggo Jønsson;Erik Hippe

  • Monitoring patients treated with anti-TNF-alpha biopharmaceuticals: assessing serum infliximab and anti-infliximab antibodies.

    M. Svenson;P. Geborek;Tore Saxne;K. Bendtzen

  • Auto‐Antibodies to Tumour Necrosis Factor a in Healthy Humans and Patients with Inflammatory Diseases and Gram‐Negative Bacterial Infections

    A. Fomsgaard;M. Svenson;K. Bendtzen

  • Immunohistological detection of interleukin I-like molecules and tumour necrosis factor in human epidermis before and after UVB-irradiation in vivo.

    Annemette Oxholm;P. Oxholm;B. Staberg;K. Bendtzen

  • Cytokines, autoantibodies and viral antibodies in premorbid and postdiagnostic sera from patients with rheumatoid arthritis: case–control study nested in a cohort of Norwegian blood donors

    Kristian T Jørgensen;Allan Wiik;Merete Pedersen;Chris J Hedegaard

  • T helper cell type 1 (Th1), Th2 and Th17 responses to myelin basic protein and disease activity in multiple sclerosis.

    Chris J Hedegaard;Martin Krakauer;Klaus Bendtzen;Henrik Lund

  • [Clinical importance of neutralising antibodies against interferon-beta in patients with relapsing-remitting multiple sclerosis].

    Soelberg Sørensen;Nils J Koch-Henriksen;Christian Ross Pedersen;Katja Maria Clemmesen

Frequent Co-Authors

Karsten Buschard
Karsten Buschard Copenhagen University Hospital
Stellan Sandler
Stellan Sandler Uppsala University
Arsalan Kharazmi
Arsalan Kharazmi University of Copenhagen
Claus Henrik Nielsen
Claus Henrik Nielsen Copenhagen University Hospital
Ole Haagen Nielsen
Ole Haagen Nielsen University of Copenhagen
Decio L. Eizirik
Decio L. Eizirik Université Libre de Bruxelles
Ulla Feldt-Rasmussen
Ulla Feldt-Rasmussen University of Copenhagen
Jørgen Holm Petersen
Jørgen Holm Petersen University of Copenhagen
Thomas Mandrup-Poulsen
Thomas Mandrup-Poulsen University of Copenhagen
Pier Luigi Meroni
Pier Luigi Meroni Istituto Auxologico Italiano

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those studying Immunology, exploring related healthcare degrees can open diverse career opportunities. Many candidates consider nursing pathways, such as the what is the easiest np program, which outlines simple entry points into nurse practitioner roles. This option can be appealing for professionals aiming to combine immunological knowledge with clinical practice.

Specializing further, psychiatric mental health nurse practitioner (PMHNP) programs offer focused training on mental health, an area increasingly intertwined with immunological research. Prospective students can find programs with strong clinical placements by reviewing the best pmhnp programs online, ensuring practical experience alongside theoretical learning.

Cost is often a deciding factor, and fortunately, some of the cheapest pmhnp programs online provide quality education without excessive financial burden. Balancing affordability with program quality is essential for sustainable career progression.

Ultimately, advancing qualifications can significantly impact earning potential. Insights into the doctor of nursing practice salary highlight how higher degrees translate to better compensation, motivating students to pursue advanced roles in healthcare.

Best Scientists Citing Klaus Bendtzen

Trending Scientists

Recently Published Articles